Thomas Finnegan, PhD1, Catherine Murray, MA1, John Maeglin, BA1 and Patricia K. Coyle, MD2, (1)Medscape Education, New York, NY, (2)Department of Neurology, Stony Brook University, Stony Brook, NY

Gavin Giovannoni, MD, PhD, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, Aida Aydemir, MSc, EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Billerica, MA, Elisabetta Verdun di Cantogno, MD, PhD, Merck KGaA, Darmstadt, Germany, Thomas P. Leist, MD, Comprehensive Multiple Sclerosis Center, Division of Clinical Neuroimmunology, Jefferson University, Philadelphia, PA and CLASSIC-MS Steering Committee

Tyler E Smith, M.D.1, Maya Madhavan, M.D.1, Daniel Gratch, M.D.1, Aneek Patel, B.S.2, Valerie Saha, NP1, Carrie Sammarco, DrNP1, Zoe Rimler, B.S.1, Guadalupe Zuniga, .1, Dunia Gragui, .1, Leigh E Charvet, PhD1, Gary Cutter, PhD3, Lauren Krupp, MD1, Ilya Kister, MD1 and Lana Zhovtis Ryerson, M.D.1, (1)Neurology, NYU Langone Health, New York, NY, (2)NYU School of Medicine, New York, NY, (3)University of Alabama at Birmingham, Birmingham, AL

Virginia R. Schobel, MSc, Spherix Global Insights, Exton, PA

Virginia R. Schobel, MSc, Spherix Global Insights, Exton, PA

Timothy Vollmer, MD1, Daniel Pelletier, MD2, Sibyl Wray, MD3, Barry Hendin, MD4, Linda-Ali Cruz, MD5, James Stankiewicz, MD5, Ratnakar Pingili, MBBS5, Xiangyi Meng, PhD5, Andy Cheadle, PhD5 and Jeffrey A Cohen, MD6, (1)Rocky Mountain MS Center, Aurora, CO, (2)Multiple Sclerosis Comprehensive Care Center At USC, Los Angeles, CA, (3)Hope Neurology, Knoxville, TN, (4)Center for Neurology and Spine, Phoenix, AZ, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)Cleveland Clinic Mellen Center, Cleveland, OH

Clara Wan, BA1, Stacey S Cofield, PhD2, Kendall Curtis, BS1, William R Meador, MD3 and John R Rinker, MD4, (1)University of Alabama at Birmingham, Birmingham, AL, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Neurology, Birmingham VA Medical Center, Birmingham, AL, (4)Neurology, University of Alabama at Birmingham, Birmingham, AL

Daniel Kantor, MD1, Bruce Bebo, PhD2, Peter Wahl, MLA, MS, ScD3, Patricia K. Coyle, MD4, Edward J Fox, MD, PhD5, Robert A Bermel, MD6, Jon V Riolo, PhD7, Diego Silva, MD7, Christina Wright, PharmD7, Wendi Malley, MPH3, Jud C Janak, PhD, MPH3 and Aaron E Miller, MD8, (1)Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, (2)National Multiple Sclerosis Society, New York, NY, (3)Corrona, LLC, Waltham, MA, (4)Department of Neurology, Stony Brook University, Stony Brook, NY, (5)Central Texas Neurology Consultants, Multiple Sclerosis Clinic of Central Texas, Round Rock, TX, (6)Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH, (7)Bristol Myers Squibb, Princeton, NJ, (8)Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY

Kottil Rammohan, MD1, David Li, MD, FRCPC2, June Halper, MSN, APN-C, MSCN, FAAN3, Sara McCurdy Murphy, BA4, Lisa Patton, BA4, Chao Zheng, MD5 and Seema Khurana, DO5, (1)Department of Neurology, Multiple Sclerosis Center, University of Miami, Miami, FL, (2)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)Consortium of Multiple Sclerosis Centers, Hackensack, NJ, (4)Social & Scientific Systems, Silver Spring, MD, (5)University of Miami, Miami, FL

Mahboobeh Fereidan-Esfahani, M.D.1, Paul Decker, M.S.2, Jeanette Eckel Passow, PhD2 and Oliver Tobin, M.B. B.Ch. B.A.O. Ph.D.1, (1)Neurology, Mayo Clinic, Rochester, MN, (2)Health Sciences, Mayo Clinic, Rochester, MN

Ciara M O’Meara, MHSc, M.A.T., BSc, RNT, RGN, Clinical Research Facility, University of Ireland Galway, Galway, Ireland

Hollie Schmidt, MS1, Sara Loud, MSEE, MBA1, Theresa Frangiosa, MBA2, Virginia Biggar, BA2, Jason Resendez, BA2 and Stephanie Monroe, JD3, (1)Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, (2)UsAgainstAlzheimer’s, Washington, DC, (3)African Americans Against Alzheimer’s, Washington, DC

Katherine L. Cardwell, BHSc1, Odessa McKenna, BSc1, Afolasade Fakolade, PhD2, Lara A. Pilutti, PhD1 and Jason Steffener, PhD3, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)School of Interdisciplinary Health Sciences, University of Ottawa, Ottawa, ON, Canada

A. Suzanne Boyd, PhD, MSW, School of Social Work, The University of North Carolina at Charlotte, Charlotte, NC and Shelby Veri, MPH, CHES, CPH, Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, NC

Doris Lill, BS, PMP Director Healthcare Access, Advocacy, Services and Research, National Multiple Sclerosis Society, Denver, CO, Kathleen Costello, MS, ANP-BC, MSCN, Can Do MS, Avon, CO, Julie Fiol, MSW, BSN, RN, MSCN, National MS Society, Bel Aire, MD and June Halper, MSN, APN-C, MSCN, FAAN, Consortium of Multiple Sclerosis Centers, Hackensack, NJ

Michelle H Chen, PhD1, Mindy Ross, BS2, John DeLuca, PhD1 and Alex Leow, MD/PhD2, (1)Kessler Foundation, East Hanover, NJ, (2)University of Illinois at Chicago, Chicago, IL

Tomicka S McMILLION, RN, DNP, MSCN, SPINAL CORD INJURY AND DISORDERS, VANJHCS, EAST ORANGE, NJ and CMSC Author’s Group

David KB Li, MD FRCPC1, Hae Jung Min, BA2, Samuel Yim, MHA3, Adelia Adelia, MSc4, Shelly Au, PhD4, Jason Shewchuk, MD, FRCPC5, Laura Barlow, RTR, RMTR6, Laura Harvey, BA4, Shannon Kolind, PhD4, Roger Tam, PhD7, Bruce Forster, MSc MD FRCPC FCAR5, Monty Martin, MD FRCPC5, Carolyn Rudden, BSc MA8, Lori Saslow, MS9, June Halper, MSN, APN-C, MSCN, FAAN9 and Anthony Traboulsee, MD, FRCPC4, (1)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (2)University of British Columbia, Vancouver, BC, Canada, (3)Vancouver Coastal Health, Vancouver, BC, Canada, (4)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (5)Radiology, University of British Columbia, Vancouver, BC, Canada, (6)UBC MRI Research Centre, Vancouver, BC, Canada, (7)Radiology & School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada, (8)British Columbia Ministry of Health, Victoria, BC, Canada, (9)Consortium of Multiple Sclerosis Centers, Hackensack, NJ

Dinesh K Sivakolundu, MD, PhD1,2, Mark D Zuppichini, MA3, Kathryn West, PhD4, Gayathri B Maruthy, MS5, Monroe Turner, PhD5, Dema Abdelkarim, BS5, Yuguang Zhao, MS5, Peter Herman, PhD6, Stephan Kaczmarz, PhD7, Fahmeed Hyder, PhD6, Robert Fulbright, MD6, Erin E Longbrake, MD, PhD1, Darin T Okuda, MD8 and Bart Rypma, PhD9, (1)Neurology, Yale University, New Haven, CT, (2)Biological Sciences, University of Texas at Dallas, Dallas, TX, (3)School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, (4)Center for BrainHealth, Dallas, TX, (5)University of Texas at Dallas, Dallas, TX, (6)Yale University, New Haven, CT, (7)Technical University of Munich School of Medicine, Munich, Germany, (8)UT Southwestern Medical Center, Dallas, TX, (9)School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX

Mark D Zuppichini, MA, School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, Dinesh Sivakolundu, MD, Department of Neurology, Yale School of Medicine, New Haven, CT, Kathryn West, PhD, Center for BrainHealth, Dallas, TX, Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX and Bart Rypma, PhD, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX

Sophie Vercruyssen, MSc1, Shannon Kolind, PhD2, Shelly Au, PhD2, Adelia Adelia, MSc2, Diana M Sima, PhD1, Dirk Smeets, PhD3, David Li, MD, FRCPC4 and Anthony Traboulsee, MD, FRCPC2, (1)R&D, icometrix, Leuven, Belgium, (2)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)icometrix, Leuven, Belgium, (4)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

Sophie Vercruyssen, MSc1, Shannon Kolind, PhD2, Shelly Au, PhD2, Adelia Adelia, MSc2, Diana M Sima, PhD1, Dirk Smeets, PhD3, Anthony Traboulsee, MD, FRCPC2 and David Li, MD, FRCPC4, (1)R&D, icometrix, Leuven, Belgium, (2)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)icometrix, Leuven, Belgium, (4)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

Zaenab Dhari, MD1,2, Steven Kracke, MSc3, Marco Pisa, MD4, Gabriele C DeLuca, MD, DPhil4, Albert C. Lo, MD, PhD5, Heather M DelMastro, MSc1,2, Mary Bailey, MD1,2 and Jennifer Ruiz, DPT1,2, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, North Haven, CT, (4)Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, (5)Departments of Neurology and Engineering, Brown University, Providence, RI

Zaenab Dhari, MD1,2, Jennifer Ruiz, DPT1,2, Lindsay O Neto, MPH1,2, Marco Pisa, MD3, Gabriele C DeLuca, MD, DPhil3, Mary Bailey, MD1,2 and Elizabeth S Gromisch, PhD1,2,4, (1)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (3)Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, (4)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Anita Shankar, M.S., Heena R. Manglani, M.A., Oyetunde Gbadeyan, Ph.D. and Ruchika S. Prakash, Ph.D., Department of Psychology, The Ohio State University, Columbus, OH

Mauricio O Bando, Neuropsychologist, Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerosis Association (ABEM), Sao Paulo, Brazil, Ana M Canzonieri, Dr, Psychology, Brazilian Multiple Sclerosis Association (ABEM), Sao Paulo, Brazil, Talita D Silva, Dr, Sao Paulo University, Sao Paulo, Brazil and Marcelo Massa, Doctor, EACH, USP – Sao Paulo University, Sao Paulo, Brazil

Aman Saini, MD, MPH1, Ilia Poliakov, BHSc (Hon), MD, FRCPC2, Katherine B. Knox, MD, FRCPC3, Chantal Kahovec, RN(NP)4, Shirley MacGowan, RN, MSCN5, Candace Lahoda, RN4, Colleen Cochran, BA (Hons.)1 and Michael C. Levin, MD, FRCPC, FAAN, FANA6, (1)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)Department of Neurology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (4)Saskatoon MS Clinic, Saskatchewan Health Authority, Saskatoon, SK, Canada, (5)Saskatchewan MS Drugs Program, Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (6)Department of Neurology and Department of Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada

Annette F Okai, MD1, Annette M Howard, MD2, Mitzi J Williams, MD3, Justine D Brink, DO, MPH4, Chiayi Chen, RN, PhD4, Tamela L Stuchiner, MA4, Elizabeth Baraban, MPH, PhD4 and Stanley Cohan, MD, PhD5, (1)Multiple Sclerosis Treatment Center of Dallas, Dallas, TX, (2)Multiple Sclerosis Institute of Texas, Houston, TX, (3)Joi Life Wellness MS Center, Atlanta, GA, (4)Providence Brain and Spine Institute, Portland, OR, (5)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR

Asya I. Wallach, MD, Matthew Schiebel, RN, Christal Radburn, RMA, MSHA, Reena Mathew, RN, Dana Jones, NP and Mary Ann Picone, MD, Holy Name Medical Center, Teaneck, NJ

Aubrie L Lindner, AA1, Renee Stewart, DNP, APRN-NP2, Kristen Bayly, BSN2, Rana K. Zabad, MD3, Joey Rubenthaler, ATP4, Nathan Reitz, ATP5, Scott Richotte, BS6, Mohamed Darwish, MD7, Kathleen Healey, NP, PhD8 and CMSC Clinical MAHA team and CRT team, (1)Neurological Sciences Program Operations Manager, Nebraska Medicine, Omaha, NE, (2)Neurological Sciences, Nebraska Medicine, Omaha, NE, (3)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE, (4)ATP, Numotion, Omaha, NE, (5)Director of Sales Operations, Numotion, Lincoln, NE, (6)VP of Sales and Clinical Relations, Numotion, Lincoln, NE, (7)Department of Neurology, University Nebraska Medical Center, Omaha, NE, (8)Neurologial Sciences, University of Nebraska, Omaha, NE

Janean W Jenkins, MSN, APRN, CNRN, CNS, NBC-HWC, Multiple Sclerosis Makeover, San Antonio, TX

Lisa Aquillano, PharmD, BCPS, MSCS, Neil Lava, MD and Calli Cook, DNP, FNP-C, FAANP, Neurology, The Emory Clinic, Atlanta, GA